Antimalarial cutaneous side effects: A study in 209 users

Cutaneous and Ocular Toxicology

Volumn 30, Issue 1, 2011, Pages 45-49

  Skare, Thelma ^a   Ribeiro, Camila Ferrari ^a   Souza, Fernanda H M ^a   Haendchen, Leticia ^a   Jordão, Juliana Merheb ^a  

^a University Evangelic Hospital of Curitiba   (Brazil)

Author keywords

Antimalarials; hyperpigmentation; pruritus; xerosis

Indexed keywords

AMIODARONE; ANTIMALARIAL AGENT; BLEOMYCIN; BUSULFAN; CHLORPROMAZINE; CLOFAZIMINE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; HYDROXYUREA; MINOCYCLINE; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DERMADROME; DRUG HYPERSENSITIVITY; FEMALE; HAIR DISCOLORATION; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; NAIL PIGMENTATION; PHYSICAL EXAMINATION; PREVALENCE; PRURITUS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN ALLERGY; SKIN COLOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; XEROSIS;

ADULT; ANTIMALARIALS; ARTHRITIS, RHEUMATOID; BRAZIL; FEMALE; HUMANS; HYPERPIGMENTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PRURITUS; QUESTIONNAIRES; SKIN; SKIN DISEASES; YOUNG ADULT;

EID: 79951603549     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2010.521225     Document Type: Article

References (11)

1. Cooper RG, Magwere T. Chloroquine: novel uses & manifestations. Indian J Med Res 2008;127:305-316.
2. Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 2007;20:160-174. (Pubitemid 350029307)
3. Paradisi A, Bugatti L, Sisto T, Filosa G, Amerio PL, Capizzi R. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and review of the literature. Clin Ther 2008;30:930-940. (Pubitemid 351799876)
4. Millard TP, Smith HR, Black MM, Barker NW. Bullous pemphigoid developing during systemic therapy with chloroquine. Clin Exp Dermatol 1999;24:263-265. (Pubitemid 29366902)
5. Millard TP, Ratnavel R. Cutaneous hyperpigmentation during therapy with hydroxychloroquine. Clin Exp Dermatol 2004;29:91-99.
6. Geraminejad P, Stone MS, Sontheimer RD. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus. Lupus 2004;13:473-477. (Pubitemid 38931781)
7. Di Giacomo TB, Valente NYS, Nico MMS. Chloroquineinduced hair depigmentation. Lupus 2009;18:264-266.
8. Marriot P, Borrie PF. Pigmentary changes following chloroquine. Proc Med Soc Med 1975;68:25-26.
9. Rood MJ, Vermeer MH, Huizinga TWJ. Hyperpigmentation of the skin due to hydroxychloroquine. Scand J Rheumatol 2008;37:158-160.
10. Reynaert S, Setterfeld J, Black MM, Hydroxychloroquine induced pigmentation in two patients with systemic lupus erythematosus. J Eur Acad Dermatol Venereol 2006;20:487-488.
11. Pelle MT, Callen JP. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 2002;138:1231-1233. (Pubitemid 35025698)